이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Charles River Laboratories International 대차 대조표 상태
재무 상태 기준 확인 4/6
Charles River Laboratories International 의 총 주주 지분은 $3.7B 이고 총 부채는 $2.6B, 이는 부채 대 자기자본 비율을 71.1% 로 가져옵니다. 총자산과 총부채는 각각 $8.2B 및 $4.4B 입니다. Charles River Laboratories International 의 EBIT는 $627.2M 이며 이자보상배율은 4.8 입니다. $327.0M 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
63.2%
부채 비율
US$2.38b
부채
| 이자 보상 비율 | 5x |
| 현금 | US$179.21m |
| 주식 | US$3.77b |
| 총 부채 | US$4.18b |
| 총 자산 | US$7.95b |
최근 재무 상태 업데이트
Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Jul 26
Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 27Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly
Jul 03These 4 Measures Indicate That Charles River Laboratories International (NYSE:CRL) Is Using Debt Reasonably Well
Apr 02Recent updates
Why Charles River Laboratories International, Inc. (NYSE:CRL) Could Be Worth Watching
Sep 10US$227: That's What Analysts Think Charles River Laboratories International, Inc. (NYSE:CRL) Is Worth After Its Latest Results
Aug 10Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)
Aug 10Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Jul 26Risks To Shareholder Returns Are Elevated At These Prices For Charles River Laboratories International, Inc. (NYSE:CRL)
Jul 11Charles River Laboratories: Fair Valuation Against Fundamentals
May 31What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
May 25Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?
Apr 27Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings
Apr 11Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues
Feb 21Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'
Feb 16Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?
Jan 17Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up
Jan 02Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth
Dec 17Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation
Nov 26Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 29% Discount?
Nov 12Charles River: Q3 Points To Ongoing Deterioration
Nov 09Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 27At US$197, Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth Looking At Closely?
Oct 12Charles River Laboratories: Diving Into The Lab (Rating Upgrade)
Oct 06Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 27% Discount?
Aug 10Charles River Laboratories: Very Attractive After The Pullback
Jul 26Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?
Jul 22Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly
Jul 03When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?
Jun 19A Look At The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)
May 01Should You Be Adding Charles River Laboratories International (NYSE:CRL) To Your Watchlist Today?
Apr 16These 4 Measures Indicate That Charles River Laboratories International (NYSE:CRL) Is Using Debt Reasonably Well
Apr 02Is Charles River Laboratories International, Inc. (NYSE:CRL) Potentially Undervalued?
Mar 19Charles River gains as Guggenheim upgrades despite post-earnings selloff
Feb 23재무 상태 분석
단기부채: CRL 의 단기 자산 ( $1.7B )이 단기 부채( $954.8M ).
장기 부채: CRL 의 단기 자산( $1.7B )은 장기 부채( $3.5B ).
부채 대 자본 내역 및 분석
부채 수준: CRL 의 순부채 대 자기자본 비율( 62.3% )은 높음으로 간주됩니다.
부채 감소: CRL 의 부채 대 자기자본 비율은 지난 5년간 108.5% 에서 71.1% 로 감소했습니다.
부채 범위: CRL 의 부채는 영업 현금 흐름 ( 26.8% )에 의해 잘 충당되었습니다.
이자 보장: CRL 의 부채에 대한 이자 지급은 EBIT( 4.8 x 적용 범위)로 잘 충당됩니다.